Ultrasound zaps a new brain spot to quiet Parkinson's tremors
NCT ID NCT06259708
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested whether low-intensity focused ultrasound aimed at a brain area called the zona incerta (ZI) can reduce tremors in 20 people with Parkinson's disease. Researchers compared this approach to the standard target (Vim) and used brain scans to understand how the treatment works. The goal is to find a better way to control tremors without surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- low intensity focused ultrasound (device)
- What this could lead to
- If successful, this could point toward a more effective brain target for ultrasound treatment of Parkinson's tremor.
- What could go wrong
- This is a small, early-stage study with only 20 participants, so results may not apply to everyone. The treatment is still experimental and may not work as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Mar 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Confirmed diagnosis of Parkinson's disease * Resting tremor score (MDS-UPDRS III 3.17 Rest Tremore Amplitude (RUE or LUE)) ≥ 2 * Between the ages of 40-80 years * Hoehn and Yahr stage between 1-3 (mild to moderate PD) in the "ON" state * Patients who are willing to have a partial (\~8 cm diameter circular area above the ear) hair shaving. Exclusion Criteria: * Atypical Parkinsonism * History of essential tremor * Dementia preventing informed consent * Change in Parkinson's medication with the last 2 weeks * Neurological disease other than PD, including Alzheimer's disease, multi-infarct dementia, Huntington's disease, normal pressure hydrocephalus, a brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, or history of significant head trauma * Unstable medical conditions or serious disease/conditions (e.g., cancer undergoing active treatment, poorly controlled diabetes) * Concurrent treatment for PD with Duodopa * Concurrent treatment for PD with deep brain stimulation (DBS) * Thickness of the temporal bone \< 7 mm * Individuals should also not participate if they have any of the following contraindications for undergoing fMRI scanning: * Cardiac pacemaker, wires, or defibrillator * Metal in eye or orbit, including the history of any eye injury involving metal fragments and increased risk due to (history of) working as a metal worker (grinding, machining, or welding) * Ferromagnetic aneurysm clip * Possibility of pregnancy * Artificial heart valve * Ear or eye implant, including cochlear implant * Brain aneurysm clip * Implanted drug infusion pump * Electrical stimulator to nerves or bones * Coil, catheter, or filter in any blood vessel * Orthopedic hardware (artificial joint, plate, screw, rod) * Other metallic prostheses * Shrapnel, bullets, or other metal fragments * Surgery, piercings or tattoos (including tattooed eyeliner) in the last six weeks * Medication releasing skin patches (i.e. nicotine, birth control, nitroglycerine) * History of claustrophobia
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of British Columbia, DMCBH
Vancouver, British Columbia, V6T 1Z3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a massive data registry crack the code of Parkinson's and related brain diseases?
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Giving Parkinson's patients a say may boost their Brain's ability to learn movement
- Brain scans probe why some Parkinson's patients freeze Mid-Step
- Can tango rewire the brain? dance program tested for Parkinson's and dementia
- Can a workout after walking practice help Parkinson's patients learn better?